Licensing deal is a relief for Adventrx
This article was originally published in Scrip
Executive Summary
Adventrx Pharmaceuticals has licensed ANX-514, its emulsion formulation of docetaxel, to Shin Poong Pharmaceutical for manufacturing, development and marketing in South Korea.